Caterina Nardella
Beth Israel Deaconess Medical Center(US)Memorial Sloan Kettering Cancer Center(US)Harvard University(US)Cancer Genetics (United States)(US)
Publications by Year
Research Areas
PARP inhibition in cancer therapy, DNA Repair Mechanisms, Prostate Cancer Treatment and Research, BRCA gene mutations in cancer, Cancer Genomics and Diagnostics
Most-Cited Works
- → Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer(2008)1,358 cited
- → Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate(2009)660 cited
- → Subtle variations in Pten dose determine cancer susceptibility(2010)574 cited
- → Combining a PI3K Inhibitor with a PARP Inhibitor Provides an Effective Therapy for BRCA1-Related Breast Cancer(2012)475 cited
- → Pro-senescence therapy for cancer treatment(2011)430 cited
- → Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence(2010)395 cited
- →